Estimating The Fair Value Of Synektik Spólka Akcyjna (WSE:SNT)
Jan 09
Have your own idea? Try our Stock Screener
Polish (WIG) Healthcare Sector Analysis
UpdatedJan 16, 2026
DataAggregated Company Financials
Companies44
- 7D2.7%
- 3M4.6%
- 1Y1.7%
- YTD5.8%
The Healthcare industry is up 1.9% in the last week, with Diagnostyka up 10%. Despite this gain, the industry's performance has been flat over the past year. Looking forward, earnings are forecast to grow by 23% annually.
Sector Valuation and Performance
Has the Polish Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 16 Jan 2026 | zł21.3b | zł19.8b | zł399.5m | 19.9x | 53.3x | 1.1x |
| Sun, 14 Dec 2025 | zł19.6b | zł19.7b | zł366.1m | 21.2x | 53.5x | 1x |
| Tue, 11 Nov 2025 | zł20.4b | zł19.3b | zł359.3m | 26.2x | 56.9x | 1.1x |
| Thu, 09 Oct 2025 | zł20.5b | zł19.2b | zł346.0m | 23.7x | 59.3x | 1.1x |
| Sat, 06 Sep 2025 | zł20.7b | zł19.0b | zł383.9m | 22.4x | 53.8x | 1.1x |
| Mon, 04 Aug 2025 | zł20.1b | zł18.8b | zł375.7m | 20.6x | 53.5x | 1.1x |
| Wed, 02 Jul 2025 | zł19.6b | zł17.6b | zł155.9m | 20.3x | 125.5x | 1.1x |
| Fri, 30 May 2025 | zł19.9b | zł17.4b | zł132.3m | 21.5x | 150.4x | 1.1x |
| Sun, 27 Apr 2025 | zł19.3b | zł17.1b | zł97.5m | 28.4x | 197.6x | 1.1x |
| Tue, 25 Mar 2025 | zł19.4b | zł16.7b | zł115.9m | 31x | 167.2x | 1.2x |
| Thu, 20 Feb 2025 | zł19.4b | zł16.6b | zł113.2m | 23.4x | 171.4x | 1.2x |
| Sat, 18 Jan 2025 | zł15.1b | zł16.7b | zł123.0m | 23.3x | 122.6x | 0.9x |
| Mon, 16 Dec 2024 | zł15.1b | zł16.7b | zł117.9m | 24.6x | 127.7x | 0.9x |
| Wed, 13 Nov 2024 | zł15.1b | zł16.4b | zł53.4m | 22.9x | 282.7x | 0.9x |
| Fri, 11 Oct 2024 | zł15.6b | zł16.4b | zł83.0m | 23.8x | 188.5x | 1x |
| Sun, 08 Sep 2024 | zł15.3b | zł16.4b | zł167.9m | 28.2x | 91.2x | 0.9x |
| Tue, 06 Aug 2024 | zł14.2b | zł16.2b | zł133.8m | 25.8x | 106.3x | 0.9x |
| Thu, 04 Jul 2024 | zł14.6b | zł16.2b | zł134.2m | 26.1x | 109x | 0.9x |
| Sat, 01 Jun 2024 | zł14.9b | zł16.1b | zł74.7m | 22.4x | 198.8x | 0.9x |
| Mon, 29 Apr 2024 | zł14.6b | zł16.0b | -zł129,953,749.00 | 38.7x | -112.4x | 0.9x |
| Wed, 27 Mar 2024 | zł14.9b | zł16.0b | -zł218,743,549.00 | 38.9x | -68x | 0.9x |
| Fri, 23 Feb 2024 | zł14.8b | zł16.0b | -zł199,514,549.00 | 41.4x | -74.2x | 0.9x |
| Sun, 21 Jan 2024 | zł14.9b | zł15.9b | -zł245,263,080.00 | 34.5x | -60.9x | 0.9x |
| Tue, 19 Dec 2023 | zł15.0b | zł15.9b | -zł245,263,080.00 | 30x | -61.1x | 0.9x |
| Thu, 16 Nov 2023 | zł13.6b | zł15.7b | zł110.2m | 31.6x | 123.8x | 0.9x |
| Sat, 14 Oct 2023 | zł13.5b | zł15.7b | zł114.5m | 31.8x | 117.9x | 0.9x |
| Mon, 11 Sep 2023 | zł14.1b | zł15.7b | zł64.2m | 20.7x | 219.9x | 0.9x |
| Wed, 09 Aug 2023 | zł14.2b | zł15.4b | zł101.2m | 24.2x | 140.6x | 0.9x |
| Fri, 07 Jul 2023 | zł14.1b | zł15.4b | zł121.8m | 25x | 115.7x | 0.9x |
| Sun, 04 Jun 2023 | zł14.0b | zł15.4b | zł176.6m | 20.5x | 79.2x | 0.9x |
| Tue, 02 May 2023 | zł13.5b | zł15.5b | zł229.4m | 26.4x | 58.6x | 0.9x |
| Thu, 30 Mar 2023 | zł13.1b | zł15.0b | zł242.6m | 26.9x | 54.1x | 0.9x |
| Sat, 25 Feb 2023 | zł13.5b | zł15.1b | zł259.2m | 29.3x | 52x | 0.9x |
| Mon, 23 Jan 2023 | zł13.5b | zł15.0b | zł237.9m | 26.4x | 56.8x | 0.9x |
Price to Earnings Ratio
56.8x
Current Industry PE
- Investors are pessimistic on the Polish Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 53.0x which is lower than its 3-year average PE of 88.7x.
- The 3-year average PS ratio of 0.97x is lower than the industry's current PS ratio of 1.1x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 19% per year over the last three years.
- Revenues for these companies have grown 9.7% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Polish Healthcare sector?
| PL Market | 1.51% | |
| Healthcare | 2.71% | |
| Healthcare Services | 5.54% | |
| Pharma | 3.80% | |
| Biotech | 1.21% | |
| Medical Equipment | -0.63% | |
| Life Sciences | -3.39% | |
| Healthtech | -3.41% | |
Industry PE
- Investors are most optimistic about the Healthcare Services industry even though it's trading below its 3-year average PE ratio of 29.5x.
- Analysts are expecting annual earnings growth of 15.6%, which is higher than its past year's earnings decline of 4.7% per year.
Forecasted Growth
- Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 59% over the next 5 years.
- This is better than its past earnings growth rate of 18% per year.
- In contrast, the Healthtech industry is expected to see its earnings grow by 11% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| DIA Diagnostyka | zł195.05 | 10.3% +zł616.1m | n/a | PE24.7x | |
| VOX Voxel | zł137.60 | 6.5% +zł88.2m | 9.2% | PE14x | |
| CLN Celon Pharma | zł21.15 | 5.2% +zł56.5m | -16.4% | PS5x | |
| BCX Bioceltix | zł82.70 | 6.3% +zł24.1m | -1.8% | PB15.1x | |
| SCP Scope Fluidics | zł144.20 | 2.1% +zł9.5m | -13.5% | PE8.4x |
